Prasad Deepa

Design Therapeutics, Inc. · Director

Prasad Deepa is listed in filings as Director at Design Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 12, 2025, including sale activity. Recent filings connect the profile to Design Therapeutics, Inc. (DSGN). The current snapshot covers public activity from Jun 17, 2024 to Jun 12, 2025. Reported amounts are shown as $76.2K to $72.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
Design Therapeutics, Inc.DSGN$24k3.8k sharesSellDec 18, 2024$6.27$12.61